Dld Asset Management, LP Dexcom Inc Transaction History

Dld Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $391,962 - $766,110	-5,765 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $141,120 - $195,299	1,500 Added 35.17%	5,765 $2.95 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $218,571 - $274,026	1,683 Added 65.18%	4,265 $2.29 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $275,525 - $369,690	2,582 New	2,582 $1.41 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Dld Asset Management, LP with notifications on news.